title: Raltegravir in pregnancy: a case series presentation.
abstract: Adequate antiretroviral therapy is essential for HIV-positive pregnant women to prevent mother-to-child transmission. We report a small case series of five women receiving raltegravir as part of their antiretroviral regimen during pregnancy.
authors.affiliation: Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg, Austria.
authors.forename: N
authors.initials: N
authors.lastname: Taylor
authors.forename: V
authors.initials: V
authors.lastname: Touzeau
authors.forename: M
authors.initials: M
authors.lastname: Geit
authors.forename: M
authors.initials: M
authors.lastname: Gisinger
authors.forename: A
authors.initials: A
authors.lastname: Egle
authors.forename: R
authors.initials: R
authors.lastname: Greil
authors.forename: A
authors.initials: A
authors.lastname: Rieger
authors.forename: R
authors.initials: R
authors.lastname: Zangerle
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018890:Chemoprevention / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000821:virology*; D011760:Pyrrolidinones / Q000627:therapeutic use*; D000068898:Raltegravir Potassium; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D044966:Anti-Retroviral Agents; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium